Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 Inhibitor, SAR443820 (DNL788), in healthy adult participants - Denali Therapeutics

Investors & News
Contact Us

11/27/2023

Share

Science

TransportVehicle™ Platform
Publications
Partnerships & Collaborations

Pipeline

Pipeline

Patients

Our Commitment
Advocacy
Therapeutic Areas
Clinical Studies
Early Access Policy

About Us

About Us
Leadership
Investors & News
Contact Us

Careers

Life at Denali
Benefits & Offerings
Internships
Postdoc Program
STEM Outreach

Legal

Privacy Policy
Terms of Use
Consumer Health Data Privacy Policy
Cookies Policy

© 2025 Denali Therapeutics